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Some of the pioneers of human genetics across Europe are described, based on a series of 100 recorded interviews made by the
author. These interviews, and the memories of earlier workers in the ﬁeld recalled by interviewees, provide a vivid picture, albeit
incomplete, of the early years of human and medical genetics. From small beginnings in the immediate post-World War 2 years,
human genetics grew rapidly across many European countries, a powerful factor being the development of human cytogenetics,
stimulated by concerns over the risks of radiation exposure. Medical applications soon followed, with the recognition of human
chromosome abnormalities, the need for genetic counselling, the possibility of prenatal diagnosis and later, the applications
of human molecular genetics. The evolution of the ﬁeld has been strongly inﬂuenced by the characters and interests of the
relatively small number of founding workers in different European countries, as well as by wider social, medical and scientiﬁc
factors in the individual countries.
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INTRODUCTION
The 50th anniversary of the European Society of Human Genetics
(ESHG) provides a good opportunity to look back on how the ﬁeld of
human and medical genetics began, and how it has developed over the
subsequent half century. The request from the ESHG Board that I
should write an informal article describing some of the founders or
other pioneers of the ﬁeld, as seen from the perspective of my series of
100 recorded interviews, is a challenge, especially given the uneven
geographical coverage of these interviews, the use mainly of English as
the interview language, and the fact that some of the earliest founders
are no longer living.
The ESHG Board recognised these difﬁculties, as is clear from the
request itself:
‘You have been working on interviews of many European geneticists,
on the EHSG and the history of genetics in Europe and we thought
this would be a great opportunity to let all the ESHG members and
beyond participate in your work and your collection.Would it be
feasible for you to work on a manuscript based on these interviews? It
should be entertaining, not too light of course, but in an easy way
telling stories and history of European genetics; of course it will never
cover all aspects, this is not the implication, but it should show
fragments of the developments and of the people behind.’
So here are what I hope will be some readable fragments of the
beginnings of human genetics in Europe, and I hope that these will
encourage others to expand them and to ﬁll in the many gaps which
inevitably exist, especially for those countries, which have been less
fully recognised internationally, or where English is less used by older
generations.
Actually, the gaps in the picture are less unbridgeable than it might
seem initially, as I realised when undertaking the interview series.
Many of the older workers in the ﬁeld who I interviewed, even when
not claiming to be true founders themselves, had been taught or
trained by people who were, and whose academic careers stretched
back to the pre-war decades when human genetics did not yet exist as
a differentiated scientiﬁc discipline, let alone a medical specialty. The
interviews provide numerous and vivid accounts of such people, now
long deceased; although the passage of time may have resulted in some
loss of accuracy, this has also allowed a more critical attitude to
emerge than might have been possible in an interview with the
individuals themselves; as well as abundant, often amusing anecdotes,
which can be found in the individual transcripts.
THE INTERVIEW SERIES
As this article is based very largely on my own interview series, it is
worth saying a few words about this. First, I must make the disclaimer
that I am not a trained historian, something that initially earned me
the stern disapproval of some of those who are! My answer to such
critics was ﬁrst, that no card-carrying historians, at least across Europe,
were undertaking a comparable interview programme, but also that
after a career of nearly 50 years in medical genetics, I had accumulated
at least 30 000 hours of interviewing experience as part of my daily
work of genetic counselling, which was likely also to have been of
some help in interviewing colleagues in the ﬁeld!
How did I start? In 2003, soon after realising that the history of
human genetics was in serious danger of being almost entirely lost,
and helping, with colleagues, to initiate the Genetics and Medicine
Historical Network, (Genmedhist), and its website (www.genmedhist.
org), I realised that if recorded interviews were to be done at all I
would have, at least initially, to do them myself. With a large number
of potential interviewees, no funding or other assistance, but with a
considerable amount of that most precious commodity, time, (I had
recently stepped down as Head of Department), I set out with a small
minidisc recorder and a simple digital camera to embark on my ﬁrst
interviews. In this article, as previously, I have assigned a number,
given in square brackets [–] to each interview, based on chronological
order. The complete series can be found on the Genmedhist website
(www.genmedhist.org/interviews) and a summary and general account
in my ‘core’ paper on the series (Harper).1
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Who to choose? I decided to follow the route of ‘rescue archaeology’
and to begin with the oldest and frailest, choosing Paul Polani [01],
(Figure 1), then almost 90 and the last surviving member of the true
founders of human and medical genetics in Britain, as the most
urgent. His fascinating account of his life and career, starting in Italy
and developing fully in Britain, can be both read and heard in the
transcript and audioclip preserved on the Genmedhist website (www.
genmedhist.org/interviews).
Incidentally, I need not have worried about ‘fragility’ in Paul’s case.
Insisting on meeting me at the train station on an icy Winter’s day, he
drove me to his home just outside London, and after around 5 hours
of conversation, including a 2 hour recording, was completely fresh
(unlike myself). At the end he insisted on taking me for dinner at his
favourite Italian restaurant, where the staff touchingly fell at his feet as
if he were a deity. After a most excellent meal and a considerable
amount of wine, he drove me (safely) back to the station – a
memorable beginning to the interview series!
Perhaps, this experience can give a practical hint to others under-
taking interviews: leave plenty of time. Although a very few inter-
viewees may be somewhat laconic, most proceed spontaneously once
started and the process is more one of delicate steering, with judicious
silence perhaps the main contribution of the interviewer, though I
always took with me a short list of key points to cover, in case they
were forgotten. Also, most people wanted to talk more widely after the
interview was over and often to show me records, books and so on,
whose future they were concerned for; they were almost always glad to
have the chance of reconnecting with their old ﬁeld of work.
After the ﬁrst few interviews I began to realise that most of those I
was seeing had played key roles in the beginnings of human
cytogenetics, mainly in the late 1950s and the 1960s. Having now in
my project reached early 2004, I could see that that there might be
merit in concentrating on this topic, especially since the 50th
anniversary of the discovery of the correct human chromosome
number in 1956 was approaching, and since most of those involved
in this were European rather than living in geographically and
ﬁnancially inaccessible America. So I changed my initial ‘rescue’ plan
and was fortunately able to interview the majority of those still living
from this period, as can be seen in my 2006 book ‘First Years of
Human Chromosomes’ (Harper),2 which also contains a CD with
audioclips from 10 of these interviews. Being no expert myself in
cytogenetics, I felt embarrassed initially by this role, but the
cytogeneticists proved to be a patient and tolerant group of people,
who were surprisingly complimentary about the end result.
After the 1956 anniversary had passed, I reverted to my original
plan, aiming to cover as fully as possible the development of the ﬁeld
across continental Europe. Fortunately there were now modest
funding possibilities for travel, albeit informal ones, as I was still
being asked to lecture on my previous research areas, such as
Huntington’s disease and myotonic dystrophy, whereas a few brave
(forward-looking?) centres were even starting to ask me to talk on
historical topics. My approach was to look at the map of Europe and
identify which key individuals were living near my place of ofﬁcial
invitation, shamelessly utilising the goodwill and local knowledge of
my hosts to achieve these interviews.
In this way a patchy framework for the history of human genetics
gradually began to assemble itself, though its fragmentary nature was
evident in every visit resulting in me being given a list of other names
of workers nearby whom I should interview. I had to plead that a
single person such as myself could not possibly undertake this, and
that a full history of human genetics across Europe could only be
achieved by a multifocal, country by country initiative involving both
geneticists and historians, and preferably with some international
coordination provided by an organisation such as ESHG.
By 2008 I had begun to realise that, although the number of
recorded interviews was still increasing, there was a growing backlog of
work involving transcription, correction and ﬁnalising interviews for
the web. This last task was especially demanding, especially since it
often involved further consent, since I had promised interviewees that
I would re-contact them if the interviews were to be made public in
their lifetime. Remarkably, hardly any declined this. So, since funding
for help with these tasks had been deﬁnitively refused, I had no choice
but to halt new interviews and do the work myself, using what clerical
help my generous but overstretched former department could give me.
The time from interview to completion proved to vary greatly,
sometimes taking up to 10 years!
When I began interviews again about 2 years later, I realised that the
ﬁeld of human molecular genetics, which I had myself been in at the
beginnings of, was now itself ‘becoming history’. Students were
speaking of ‘the old days when the Huntington’s gene was isolated’,
whereas for me this still seemed like just a few days ago! So here was a
new group of ‘pioneers’ which my previous interviews had hardly
touched.
Added to this, a whole group of people who I had not interviewed
because I felt they were 'too young’, (I had previously loosely
considered as ‘old’ those older than myself!) were now, disconcertingly
for me, starting to retire. This further convinced me that I had
undertaken a task impossible for a single individual, so I decided to
focus on some of the key ﬁgures in human molecular genetics, and
then to conclude the series once it had reached the arbitrary but
satisfying number of 100.
With hindsight, I now realise how fortunate I have been in living
long enough to ﬁnally reach this target, to see the end results placed on
the Genmedhist website (now itself under the auspices of ESHG and
accessible via its own website as well as from www.genmedhist.org),
and for my brain still to be functioning sufﬁciently to write some
further accounts, such as this one, to bring the series to the attention
of the wider human genetics community and to others. A paper
summarising the interview series has just been published (Harper).1
HUMAN GENETICS ACROSS EUROPE
When considering an entire continent such as Europe, with its
complex and multi-stranded social, cultural and scientiﬁc history, it
Figure 1 Paul Emanuel Polani (1914–2006). Courtesy of Paediatric
Research Unit, Guy’s Hospital, London.
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does not make sense to take a purely linear approach to the
development of human genetics. Indeed, as the interview series
progressed, the multifocal origins of the ﬁeld became increasingly
apparent and future historians will need to take this complexity into
account, rather than seeking to ﬁt the different patterns observed into
a single model. So I shall here take principally a country by country
approach, necessarily very incomplete but hopefully reasonably
accurate, though it will certainly need modifying as the topic becomes
better documented, both from interviews and from written records.
The book edited by Dronamraju3 contains a number of earlier
accounts from individual countries.
An appropriate grouping of countries with which to begin would
seem to be that of Scandinavia, including Finland, though those from
outside the region generally have a somewhat simplistic idea of these
countries as being rather uniform in scientiﬁc as well as social terms,
whereas there are some marked differences as well as afﬁnities between
them in the development of human and medical genetics.
Denmark
In the Summers of 2004 and 2005 I undertook rather extensive visits
to Denmark, Sweden and Norway, made possible in part by an
invitation from the Mendelian Society of Lund, probably the oldest
Society for genetics in the world (Harper).4 The interview with Jan
Mohr, [51] based in Copenhagen for most of his career, was actually
carried out in Oslo, to where he had retired; this was one of the key
interviews for the history of European human genetics generally, in
view of his founding role for ESHG, about which I have written
elsewhere in this 'special issue' (Harper).5 It was also a great pleasure
in personal terms to have this conversation, as I had previously been
somewhat critical of him at the time of the reform of the Society
beginning in 1988, when it met in Cardiff. A further link was our
mutual interest in the mapping of the myotonic dystrophy gene, with
linkage to the secretor and Lutheran blood group loci, the ﬁrst
example of autosomal genetic linkage in humans, found by Mohr as
long ago as 1951 (Mohr J).6
The history of Mohr’s long career in human genetics encompasses
both Norway and Denmark, but taking the Danish part ﬁrst, he
initially worked with and then in 1966 succeeded Tage Kemp in his
Copenhagen ‘Institute of Hereditary Biology' after Kemp had died
while still in post. Mohr brought to the Institute his experience in
blood group genetics, acquired at Lionel Penrose’s Galton Laboratory
in London, having earlier spent a year there, following a year in mouse
genetics with LC Dunn at Columbia University.
Mohr built up the Copenhagen Institute into a major and
comprehensive research centre, making a series of notable achieve-
ments in human gene mapping, including mapping of the cystic
ﬁbrosis locus (Eiberg et al., 1995)7 now often mistakenly attributed to
DNA techniques. In this he was greatly helped by having the
exceptionally able and practical Hans Eiberg to run his genetic marker
laboratory, developing both a series of protein markers and then
molecular techniques. As Mohr said in the interview:
‘The real reason I hired him, I think, was that he was so clever at
making orchids sprout.’
I was able to interview Hans Eiberg subsequently [95], who
conﬁrmed the symbiotic nature of their work together. Eiberg, who
had begun his career as a laboratory technician, had the invaluable
practical skills and ingenuity, whereas Mohr contributed the broad
ideas (Figure 2). Eiberg also emphasises their warm personal relation-
ship, something to be set against the difﬁculties that Mohr had with
some other colleagues.
At this point I must return to Jan Mohr’s predecessor, Tage Kemp
(1896–1964), who can truly be considered the founder of Danish
human genetics, his unit dating from 1935 and set up with support
from the Rockefeller Foundation, which had already developed a far-
sighted (though ill-fated in the light of the impending war) policy of
funding promising workers in human genetics across Europe. Kemp’s
work was strongly focused on hereditary disorders and he encouraged
a series of young clinicians in a wide range of specialties to undertake
genetic studies of disorders in their own ﬁeld. The resulting theses
were published as a remarkable series of monographs, ‘Contributions
from the University Institute for Human Genetics, Copenhagen',
amounting to 42 in total, with a summary of the volumes published
up to 1948. Along with Julia Bell’s earlier ‘Treasury of Human
Inheritance' volumes8 (Bell 1922–1958) and the American studies of
Madge Macklin on hereditary eye diseases and cancers (eg, Macklin),9
these early studies, continued in the case of the Danish series into the
1960s and succeeded by the journal Clinical Genetics founded by
Figure 2 (a) Jan Mohr (1921–2009), courtesy of Hans Eiberg, Copenhagen. (b) Hans Eiberg (Born 1945).
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Mohr, with Scandinavian co-editors Kåre Berg and Arvid Böök, can be
considered as part of the beginnings of medical as well as of human
genetics.
Some of Kemp’s views now seem uncomfortably close to eugenics,
but after the end of the war his institute was seen as the one most
suitable to host the ﬁrst International Congress of Human Genetics,
held in Copenhagen in 1956, opportunely just after the recognition by
Tjio and Levan, based in nearby Lund, of the correct human
chromosome number (Tjio and Levan),10 and allowing Tjio to present
this as an exhibit. Jan Mohr, working with Kemp at the time,
remembered the extensive work involved with this congress as a
painful experience, and speciﬁcally cited it as a strong reason for
making sure that a comparable burden would not be repeated when
the new ESHG was founded a decade later, as recounted in my article
on this subject (Harper).5
The records of the Copenhagen Institute under both Tage Kemp
and Jan Mohr have been comprehensively archived and made part of
the Danish National Archive; they are currently located in the
Institute’s present home, the Panum Institute, and have been used
both by Danish historian Lene Koch, and by myself in relation to the
beginnings of ESHG, but they deserve much greater study. At the time
of my ﬁrst visit, the Archive was deteriorating seriously, but
fortunately remedial work by archivist Erik Kann from the Danish
National Archives has ensured that it should be secure for the future.
Of course Jan Mohr and Tage Kemp were not the only important
founders of human and medical genetics in Denmark; cytogenetics,
especially its service aspects, was pioneered by Margareta Mikkelsen,
who sadly died before I was able to arrange an interview, whereas there
are others, in Copenhagen and elsewhere, whose memories deserve to
be put on record, including Bengt Harvald and Mogens Hauge who
created a Danish twin register in 1954, which continues to be
productive to the present day. My third Danish interview, though,
with ophthalmologist Mette Warburg [17], was an unusual one; it
gives a valuable account of the work that a genetically orientated
clinical specialist can achieve, in her case the area of malformation
syndromes associated with eye defects. Ophthalmologists across
Europe have indeed played a particularly important role in early
human genetics, including Waardenburg from Netherlands, François
from Belgium, and Franchescetti and Klein from Switzerland. The
interview also documents the prejudices and difﬁculties facing women
in academic medicine at the time, hopefully something that has now
disappeared, at least in its most extreme aspects, from most of Europe.
Norway
The post-war history of human genetics in Norway has been closely
linked with that of Denmark, due largely to the fact that Jan Mohr,
brought up and trained medically in Oslo, spent a further 10 years
there building up a human genetics unit, after his initial time in
Copenhagen. However, delays in creating a full Chair in Oslo resulted
in Mohr accepting the offer to succeed Kemp in Copenhagen, and
though Oslo at once promised him what had previously been delayed,
it was too late.
The upshot was that in 1967 the Oslo Chair was offered to Mohr’s
colleague and close friend Kåre Berg, at the time working in New York
with Alexander Bearn. Berg remained head of this department and the
dominant ﬁgure in Norwegian human genetics for the next 35 years; I
interviewed him in Oslo in 2005 [49], on the same day as Jan Mohr,
and it was fortunate that I did so, as he died not long afterwards, as
also did Mohr, showing how unwise it is to put off opportunities for
making recorded interviews.
Kåre Berg (Figure 3), like many others that I interviewed who had
built up their units from the starting point of a single person, was
clearly ﬁnding retirement difﬁcult and that it was hard to adjust to no
longer being the key individual for his country in the rapidly
expanding area of human, especially medical genetics, as it moved
to a more multi-centred structure. On the other hand, his interview
describes how he was able to develop valuable political and other links
which helped the specialty to evolve rapidly, something that is
probably easier to achieve in a small country. It is notable that
Norway was the ﬁrst European country to formally recognise medical
genetics as a full clinical specialty.
Berg’s own special ﬁeld was the genetics of lipoproteins and
coronary heart disease, but his unit progressively broadened its base,
with cytogenetics and associated genetic counselling developed early by
Anton Brogge and Carl-Birger van der Hansen, who I was also able to
interview jointly [50] and who gave me valuable information about the
earliest years of Norwegian genetics. More recently, two key clinical
geneticists in Oslo, Karen Ørstavik and Arvid Heiberg, have been
interviewed by Dr Trine Prescott, as part of the new ESHG supported
interview series.
The pre-war years in Norway were indeed unusual ones. The
founder of Norwegian human genetics was Otto Lous Mohr, uncle of
Jan Mohr, who was medically qualiﬁed, but had also trained in
classical genetics with Thomas Hunt Morgan and Alfred Sturtevant at
Columbia University in the 1920s. Mohr returned to Oslo as Professor
of Anatomy and wrote a valuable early book for physicians, Heredity
and Disease (Mohr OL),11 but never built up a human genetics unit
himself, though he helped others with the genetic aspects of diseases
that they had discovered (such as Fölling with phenylketonuria).
In the 1930s Mohr and other Norwegian geneticists were faced with
political pressure to allow eugenicists, notably Jon Alfred Mjoen, to
represent Norwegian genetics internationally, but they joined ranks to
successfully oppose this. After the Nazi invasion of 1940 Mohr and a
number of others were imprisoned and the university system was
largely closed.
Figure 3 Kåre Berg Oslo (1932–2009).
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A marked incident reﬂecting these tensions resulted from the fact
that Lancelot Hogben, a key ﬁgure then in British genetics, was at the
time visiting Oslo to lecture; the morning after his lecture he was being
driven to the airport to return to London when they met Nazi troops
driving towards the city, the initial forces of the invasion. They at once
headed for the Swedish by a remote road, from where Hogben was
able to cross safely into neutral Sweden. Once there he made a base
with his friend Gunnar Dahlberg in Uppsala, equally opposed to
eugenics, but was only able to return to Britain by the somewhat
circuitous route of Russia, the Trans-Siberian railway and North
America, eventually reaching Britain some three years later
(Hogben).12 Incidents like these (and many worse) need to be taken
into account when charting the post-war development of European
human genetics, as they illustrate how research, personal contacts and
most of the scientiﬁc infrastructure across the continent were
destroyed by the war and its aftermath, apart from a few geographical
and political islands such as Britain and Sweden, to which I now turn.
Sweden
Sweden, with its considerably larger population than other Scandina-
vian countries, strong industrial base and its World War 2 neutrality,
was an early pioneer in basic genetics, and during the 1930s had
developed strong agricultural institutes such as that at Svaløf, near
Lund in Southern Sweden, which were pioneering new techniques in
plant cytogenetics. It is not surprising that Lund University, the closest
academic centre to Svaløf, was also prominent in genetics and that it
should have been the place where the human chromosome number
should have been correctly determined in the closing days of 1955
(Tjio and Levan).10 My ﬁrst visit there to document the early history
of human genetics was in 2004, courtesy of the Mendelian Society of
Lund, and although I did not at this time attempt to make any
recorded interviews, I was able to meet a number of the key early
workers, though the two key protagonists of the 1956 discovery, Albert
Levan (1905–1998) and Joe Hin Tjio (1919–2001), were no longer
living.
Levan was originally a plant cytogeneticist at Svaløf, but moved to
the Lund Institute of Genetics to lead a small unit focused on cancer
cell chromosomes. He developed strong links with American cancer
centres and visiting workers to Lund included Joe Hin Tjio, Originally
from Indonesia but later based in Spain, who had considerable
technical expertise, including photomicrography (Levan himself pre-
ferred to draw chromosomes). Levan’s work on cancer cells empha-
sised the need for an accurate determination of the normal human
chromosome number and it was his collaboration with Tjio that
provided the successful and unexpected resolution to this (Figure 4).
The discovery that the human diploid chromosome number was 46,
rather than 48 as had been believed for the previous 30 years, has been
written about previously, by myself and others (Hulten,13 Harper2),
but 50 years later the subject was still a sensitive one when I visited
Lund, owing to the controversies concerning priority between Tjio and
Levan, and I found that it had been largely a ‘taboo' subject despite
both protagonists being no longer living. In this situation being a
foreigner, not a cytogeneticist, and largely ignorant of the local
situation, was a great advantage, encouraging free discussion that
might not have been possible otherwise. In fact this was something
that I experienced repeatedly throughout the interview series – not
that I would advocate ignorance as a virtue in the interviewing process!
The unexpected ﬁnding that resulted from my visit was that the 46
chromosome number might in fact have been discovered almost 2
years earlier, by the wife and husband team, Eva and Yngve Melander,
also working on chromosomes in the Lund Institute of Genetics. Their
work is very brieﬂy mentioned in the 1956 Tjio and Levan10 paper,
and I was able to meet them both at the residential home where they
were then living. I have two main memories, one irrelevant but the
other highly relevant, of this visit. The irrelevant one is that, when my
host, Ulf Kristoffersson and I arrived at lunchtime, the residents were
all enjoying a gargantuan meal, including a ﬂat-ﬁsh whose diameter
exceeded that of the plate – I made a mental note that Sweden must be
a good place to grow old! The highly relevant memory was that, when
we were leaving after our discussions, Eva Melander rummaged in her
handbag and presented me with a photograph of chromosomes, on
the back of which was inscribed: ‘46 XY human chromosomes; May
1954'. To my knowledge, no one, at least no one then living, had been
shown this before, and my host nearly fell through the ﬂoor in
astonishment.
Eva Melander was deﬁnite that her results had been shared with
Albert Levan, but her own studies were terminated because she was
unable to ﬁnd the ‘missing' chromosomes; when I asked her why she
had not published the ﬁndings, she replied that they were not
considered to be convincing until after Tjio’s later work conﬁrmed
Figure 4 (a) Joe Hin Tjio (1919–2001) demonstrating the normal human chromosome number at the ﬁrst International Congress of Human Genetics, Copenhagen,
in 1956. Photo courtesy of Victor McKusick. (b) Albert Levan (1905–1998) (seated) with Lund colleagues; courtesy of Reinards Hochberg, University of Lund.
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them, and that their quality was inferior to his – undeniable but sad
nonetheless. I felt happy that I was able to use the photograph in my
book ‘First Years of Human Chromosomes' (Harper),2 albeit more
than 50 years later.
Albert Levan (Figure 4b) continued working on cancer chromo-
somes for the rest of his life, and this theme has remained an
important one for Lund up to the present through the work of Felix
Mitelman, who I was able to interview considerably later [92]. His
story is a remarkable one, beginning in the Arctic North of Sweden,
where his parents had gone to work as dentists after leaving post-war
Poland. Studying initially at Uppsala and then Lund, he began to work
on cancer cells early, ﬁrst as a pathologist but then more clinically,
being appointed as head of a new medical genetics department, though
as he notes in the interview, one without staff, labs, ofﬁces or anything
else. (Actually most of the early medical genetics departments across
Europe started like this, perhaps a testimony to our ingenuity and
persistence as a group where funding issues are concerned!)
Mitelman’s great contribution, in addition to his own studies, has
been his success in bringing together the growing body of work on
cancer chromosomes, through international workshops and his
‘cancer chromosome database' (Mitelman).14 He was able to help this
evolve into the molecular era with identiﬁcation of speciﬁc cancer-
related genes, which gave a biological basis to the previously confusing
plethora of chromosomal changes found by early workers. Increasingly
this work is resulting not only in more speciﬁc diagnosis but also in
targeted treatments.
The area of clinical genetics and genetic counselling in Sweden,
whether in Lund or other centres, has until recently taken a subsidiary
place to more basic human genetic research, and has only recently
become strong in its own right. Possibly this is due to the longstanding
prominence of the country in design and the development of
machines? Certainly Stockholm provides a good example of this in
the person of Torbjorn Caspersson (1910–1997), who made signiﬁcant
advances in the chemical properties of nucleic acids from the 1930s,
and who according to his former colleagues Lore Zech and Jan
Lindsten, was completely ﬁxated with machines, but not at all
interested in the biological signiﬁcance of what was being measured.
Caspersson seems to have been a difﬁcult person to collaborate
with, and even more so as a colleague, yet kind and helpful to any of
his staff with personal difﬁculties. My interview with Lore Zech (1923–
2013) [28] gives a frank assessment of his character; as I often found in
the series, her situation was not made easier by her being a woman.
Things were not helped for Caspersson’s colleagues by his insistence
on more than two authors on all papers and on alphabetical order, so
that all publications ended up as ‘Caspersson et al' regardless of his
degree of involvement in the work. Anecdotes still persist in Stock-
holm about the empty chair left for ‘et al' at a formal dinner!
The discovery of chromosome banding resulting from quinacrine
mustard ﬂuorescence (Caspersson et al)15 is the work best known to
human geneticists as being associated with Caspersson and Zech
(Figure 5), yet according to Lore Zech, Caspersson was not only not
involved in the work but for a considerable time refused to believe it.
As with Levan’s work it had a botanical origin, but was soon
recognised to be universal. Zech considered her most important
contribution was for banding to allow speciﬁc identiﬁcation of the
human Y chromosome.
Caspersson’s unit was based at Stockholm’s Karolinska Institute, but
clinical cytogenetics and wider medical genetics were developed at the
nearby Karolinska Hospital, where Jan Lindsten, who I was also able to
interview [27], had set up a group, which for a time also contained
Maj Hulten, later in Birmingham UK, where I was able to interview
her too [10]. Lindsten had begun his genetics work while a medical
student in Uppsala, where he worked closely with Marco Fraccaro,
from Pavia, Italy [09], at the time of discovery of the ﬁrst human
chromosome abnormalities.
Uppsala had been prominent in genetics from an earlier time, too,
in the 1930s, and reﬂected the considerable tensions then between
genetics and eugenics. Eugenicist Herman Lundborg had set up a ‘race
biology' unit based on German ideas, but was succeeded by strongly
anti-eugenics population geneticist Gunnar Dahlberg, who as we have
seen earlier, gave refuge to Lancelot Hogben after the German invasion
of Norway. Pressures were strong in Sweden, fearful for its neutrality,
to follow Nazi ideology, and some kind of uneasy co-existence seems
to have resulted. By the time that Fraccaro and Lindsten were in
Uppsala, around 1960, the institute was headed by Jan-Arvid Böök,
but his serious health and other problems led them to leave, to set up
their own units in Pavia and Stockholm respectively.
Finland
From the viewpoint of my interview series, Finland is characterised by
lost opportunities, as I failed to interview two of the three key people
in Finnish human genetics. The ﬁrst of these, Reijo Norio, I can give
no excuse for, except that on my visits to Finland I was not trying to
undertake interviews; fortunately he has since been interviewed by
Finnish colleagues. Norio was responsible for developing the ﬁrst and
principal genetic counselling centre in Finland, based at an indepen-
dent charitable foundation in Helsinki, Vaestoliitto. He also made the
ﬁrst detailed clinical and geographical documentation of the hetero-
geneous group of recessively inherited disorders known collectively as
the ‘Finnish disease heritage' (Norio),16 the genes for which were later
isolated by Albert de la Chapelle and his colleagues and their
prevention led by Leena Peltonen, whose early death prevented me
from interviewing her. My interviewing was thus conﬁned to Albert de
la Chapelle (Figure 6), now living and still working in America.
His interview [84] yet again gives a vivid account of childhood in
wartime Finland, though he was fortunate in his family escaping direct
losses. His entry into genetics was through adult medicine, endocri-
nology and the sex chromosome disorders, leading him to cytogenetics
and then to molecular research to identify the sex-determining gene
Figure 5 Torbjorn Caspersson (1910–1997) and Lore Zech (1923–2013),
Stockholm. (Courtesy Lore Zech).
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on the Y chromosome. Having lost the race to ﬁnd this (see also the
interview with Peter Goodfellow [98]), he turned to the task of
mapping and isolating the Finnish disease heritage genes, the ﬁrst of
which was that for diastrophic dysplasia. His approach was to have a
team of three workers for each disease, a graduate scientist, a clinical
Fellow and himself.
By now his institute in Helsinki had become a major centre – he
had been appointed to the Chair of Human Genetics there back in
1974 – and he turned to cancer genetics, mapping the ﬁrst gene for
Lynch syndrome before moving to Ohio to continue his cancer
genetics research.
As a postscript to Scandinavian human genetics I need to say a word
about eugenics in these countries. I have already mentioned the
tensions involved in the pre-war and wartime years, but in contrast to
most of Europe, many of the ideas, largely shorn of their previous
coercive nature and Nazi associations, were quietly introduced into
post-war social and medical developments, such as the legalisation of
sterilisation and pregnancy termination, under left wing social demo-
cratic governments. This caused a major public furore when it became
widely known, but in fact they had been implemented largely for the
beneﬁt of those involved and reﬂected pragmatic policies rather than
ideology. This is well discussed in a book by Broberg et al,17 which
makes salutary reading when, as is now the case, ‘eugenics' is a
pejorative term and one often used with widely differing meanings.
Netherlands
I was able to interview ﬁve workers from the Netherlands, an
inadequate number for a country which, though small, has contrib-
uted disproportionately for its size to European human genetics. Those
that I did see, though, gave me a large amount of information on the
overall development of the ﬁeld, not just their own work.
Lou Went of Leiden, aged 92 at the time of my visit, was the oldest
person in my interview series [79], whereas Hans Galjaard (Figure 7),
based in Rotterdam [76], had been the pivotal person in promoting
the development of medical genetics services across the country, in
addition to his own outstanding work on inherited metabolic
disorders and their prenatal diagnosis.
Initially human genetics in the early post-war period seems to have
developed partly around cytogenetics and radiation genetics, in units
such as that of G Anders (Groeningen), but also with the help of a
number of imported scientists appointed to Chairs, notably in Leiden,
such as Marco Siniscalco from Italy and Martin Bobrow and Peter
Pearson from the United Kingdom. A number of outstanding clinical
specialists were also strongly interested in genetics, such as Petrus
Waardenburg (inherited eye disease), neurologist George Bruyn
(Huntington’s disease) and Jaap Bethlem (muscular dystrophies),
giving strong foundations for later developments in the molecular
genetics of these ﬁelds.
One of Hans Galjaard’s notable achievements was to work closely
with the health insurance system leaders to convince them of the value
of medical genetics and to encourage them to promote its develop-
ment in the different medical academic centres across the country.
This proved especially valuable when human molecular genetics
arrived, with a carefully planned system of sharing responsibility for
different major disorders, linked to research in the particular ﬁeld and
ensuring that high quality services and research were spread across the
country and wasteful duplication avoided.
Galjaard also proved to be a charismatic communicator of genetics,
and of science in general, to the general public, both on television and
by his writing, something that greatly beneﬁted human genetics, but
earned him the disapproval of a number of ‘serious' Netherlands
scientists. When I left Hans Galjaard he was busy organising an
exhibition for the public on the theme of ’Science and Beauty', his
enthusiasm for communication with people at large undiminished.
In Leiden I was able to interview two workers who have made
major contributions to human molecular genetics, in particular to
Duchenne muscular dystrophy. In a good example of the symbiotic
approach, GertJan van Omenn [78] focused on the basic molecular
research aspects, whereas his colleague Bert Bakker [77] developed
molecular genetic diagnostic services, primarily for Duchenne mus-
cular dystrophy but serving as a model for broader molecular genetics
applications worldwide, and especially across Europe. Some of these
contributions appear in two ‘Witness Seminar' publications on Human
Molecular Genetics in Medicine and Human Gene Mapping (Jones and
Tansey18,19). My other Netherlands interview was with Han Brunner,
of Nijmegen [99], who illustrates how valuable the research of a
broadly based and scientiﬁcally orientated clinical geneticist can be in
forming a bridge between basic scientists and clinicians in human
genetics.
Overall, I was struck by the value of the pragmatic Dutch approach to
human genetics, both in research and in health service applications, and
most of all by the importance of forging close links with those actually
responsible for funding and implementing major innovations, who
themselves also seem in The Netherlands to have been a far-sighted
group of people, providing they were approached in a way that they could
understand. There is a lot that everyone can still learn from this example.
Belgium
With its linguistic divide, Belgium is not an easy country to assess, at
least for an outsider.
Figure 6 Albert de la Chapelle, Helsinki (Born 1933).
Figure 7 Hans Galjaard, Rotterdam (Born 1935).
Pioneers of European human genetics
PS Harper
7
European Journal of Human Genetics
My interviewing experience has been entirely conﬁned to Dutch-
speaking Flanders, and within this to Leuven, which is the major
integrated human genetics centre, and with which I already had close
professional links.
Nevertheless, French-speaking Belgium can undoubtedly provide
one of the earliest pioneers of human cytogenetics in the person of
Hans de Winiwarter, whose studies came closest of any early worker to
identifying the correct human chromosome number in 1912
(Winiwarter).20 His estimate of 47 chromosomes may have been
inﬂuenced by the fact that he did not accept the existence of a human
Y chromosome, but he very wisely concluded that the technical
limitations of the time meant that one could not decide on an exact
number; if other later workers had been as cautious, the erroneous
estimate of 48 would probably not have become entrenched for over
30 years.
Another early contributor to human cytogenetics was Frans
Janssens, based in Leuven, who identiﬁed chiasmata at meiosis and
recognised their role in crossing-over. And it was in Leuven that
Herman vanden Berghe (Figure 8), who died very recently in January
2017, was able to develop medical genetics from the 1960s, having a
major role in creating a network of centres across the country.
Vanden Berghe [66], like many of the founding medical geneticists,
was medically trained but strongly scientiﬁcally orientated. He was
based initially in cancer research and cell culture, extending this to
cytogenetics in the early 1960s, and building up different areas of
medical genetics research by sending young colleagues to American
centres for post-doctoral research. From this solid base, and from
close contacts with government ministers and the health insurance
system, he was able, like Galjaard in Netherlands, to facilitate prenatal
diagnosis (not easy in a mainly Catholic country), and to see health
service funding provided to develop genetic services in a strictly
limited number of academic centres on a geographical basis. His
approach to this must have required a forceful personality to over-
come the rivalries between groups of workers:
‘Formally for clinical genetics no centre dates back earlier than 1974
because actually on behalf of the minister I went around the country
and founded these centres; brought people together. In Liège for
example there were 3 candidates. We gathered in a café and I told
them there would be one lab which would be funded. Now you can go
out and shoot each other and I will see who comes back or you can
agree. And they agreed to work together.’
Vanden Berghe’s ‘second generation' of workers, including Jean-
Jacques Cassiman, Gerry Evers Kiebooms and Jean-Pierre Fryns (the
last of whom I interviewed [65]) were a talented group of people, who
ensured that the greatly enlarged Leuven Institute continued to
ﬂourish after its founder’s (reluctant) retirement. Now this entire
second generation has also retired, showing the importance of
documenting these early developments as fully as possible while there
is still time.
I cannot leave Herman Vanden Berghe without mentioning his
special interest – the French hunting horn! His interview describes
how he developed a lifelong passion for this unusual instrument, and
he later sent me a CD of his group performing music for it (now
deposited in the archive of the interviews project), another illustration
of the multifaceted talent of so many of these pioneers.
Inevitably this account is biased towards Leuven and ignores other
important units in Belgium where I was unable to make interviews. As
I have already noted, a full and accurate picture can only be obtained
by each country undertaking a series of interviews with its own key
workers, and by preservation of the relevant written history. Fortu-
nately, such a programme is now beginning for Belgium.
Germany
Much has already been written about eugenics in Germany under the
Third Reich, and about how many eminent German geneticists were
either complicit or directly involved with the abuse and atrocities.
More recently, historians are starting to study post-war genetics,
whereas the special problems of communist East Germany are also
receiving attention. Knowing this, I realised that I could not possibly
undertake a major study with any validity; in fact I had initially
decided to omit Germany from my interview series entirely, but by
good fortune I was informed at the end of 2003 by my friend
and colleague David Cooper that his predecessor as editor of the
journal Human Genetics (originally Humangenetik), Friedrich Vogel
(Figure 9), was seriously ill but would be happy to see me.
So I travelled to Heidelberg without delay and fortunately found
him much improved. The resulting interview [05], although inevitably
subjective, provided what I think are some valuable insights into the
post-war development of German human genetics, of which I give a
few here.
Vogel had been captured as a young soldier on the Russian front,
but was fortunate in being released early, rather than only after several
years or never, like so many others. After medical studies in Berlin he
decided to study genetics, having concluded that his initial preference,
psychiatry, had insufﬁcient scientiﬁc basis. (Interestingly a number of
other early human geneticists who I interviewed also had psychiatry as
their original ﬁeld of interest).
Vogel went to study with Hans Nachtsheim, primarily a plant
geneticist, but also with dubious connections with the previous
regime. He wisely advised Vogel to study human mutation, now a
favoured topic on account of radiation concerns, with the result that
in now classical work he studied the mutation rate in retinoblastoma
(Vogel).21 Vogel was able to establish links at the 1956 Copenhagen
congress with James Neel and also with Arno Motulsky, of Seattle,
who became a lifelong friend and collaborator. Their joint book,Figure 8 Herman vanden Berghe, Leuven (1933–2017).
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Human Genetics, Problems and Approaches (Vogel and Motulsky),22
rapidly became the benchmark textbook for the ﬁeld internationally.
Meanwhile, the (West) German government had decided to
establish a series of Human Genetics institutes, and Vogel, still young,
was appointed to the new Chair at Heidelberg, despite manoeuvring
by the still inﬂuential network of older formerly Nazi scientists. Vogel
was also asked by Springer publishers to start an entirely new journal,
Humangenetik, (now Human Genetics), with Arno Motulsky as co-
editor. This combination of activities allowed Vogel to have a key role
in bringing Germany back into the mainstream of European human
genetics after a long period in the wilderness.
A further landmark directly involving Vogel was the organising of
the 1986 International Human Genetics Congress in Berlin, giving the
opportunity of re-establishing links with East Germany. Vogel’s
contacts in the then divided city put him in a good position to
negotiate for attendance of those in the East.
It is important that the considerable number of early human
geneticists still living from both West and East Germany are
interviewed soon, so that a fuller picture can be obtained from
different angles. I have also not seen a detailed account of the split that
led to a new Human Genetics Society, free from the lingering
inﬂuence of the previous generation. Fortunately, a number of
younger German historians are beginning to study these aspects.
Russia
The history of Russian human genetics is a tragic one; although some
of those currently in the ﬁeld are prominent internationally in research
and are attempting to develop genetic services comparable to those
found over most of Europe, the shadow of events beginning over 80
years ago still hangs heavily over the ﬁeld. In the 1930s, the country
was a world leader in general and human genetics, but by the outbreak
of World War 2 all of this research, and many of the people leading it,
had been swept away, a process completed a decade later with the
banning of all teaching of orthodox genetics, the destruction of
textbooks and animal and plant research stocks, and even a denial of
the existence of genes and of chromosomes as the basis of heredity.
Amazingly this bizarre situation lasted until the mid 1960s, well
after the structure of DNA was known and chromosome abnormalities
recognised as underlying some major genetic disorders. Workers tried
to disguise their research by hiding it under more innocuous labels
such as ‘Paediatrics' or ‘Microbiology', but essentially all areas of
genetics were a ‘taboo' subject. The only type of genetics allowed was
that promoted by the fraudulent agronomist Lysenko, which had the
inheritance of acquired characteristics as its deﬁning feature and
denied not only Mendelism but all classical genetics.
Although Lysenko was the person who ruthlessly enforced these
views, they were directly promoted and supported by Stalin himself,
and also by Nikita Kruschchev after Stalin’s death. Inheritance of
acquired characteristics suited Stalin both personally and politically,
but as with all false science, it eventually collapsed under its own
weight of contradictions, though not before it had caused immense
and permanent damage to Russian biological sciences and resulted in
the death of numerous workers in genetics. This disastrous saga, a
major factor in the eventual downfall of Russian communism, has
been much written about from the viewpoint of agriculture and
general genetics (see Medvedev),23 but its equally profound effects on
human and medical genetics have received relatively little attention.
I have had a longstanding interest in this topic for many years, since
ﬁrst reading the book by Zhores Medvedev ‘The Rise and fall of TD
Lysenko' (Medvedev).23 This was reinforced by the somewhat surreal
experience of attending the 1978 International Genetics Congress in
Moscow, by which time genetics had been partly rehabilitated but
Lysenko’s errors and crimes were still not admissable. It was not until
after the fall of the Soviet Union that I was able to visit ﬁrst St
Petersburg, then Moscow, to try to ﬁnd out more about the history of
Russian human genetics and to make some recorded interviews. I shall
here conﬁne myself to these interviews, though I still hope to write a
more detailed paper on the wider topic; a brief account is given as
chapter 16 of my ‘Short History of Medical Genetics' (Harper).24 I
must record here, though, that by 1936 Moscow had the ﬁrst and
certainly the largest Medical Genetics Institute in the world, with over
200 medical staff, advanced cytogenetic research and its own Journal.
All of this was destroyed in 1937 on the orders of Stalin, while its
Director, Solomon Levit, was executed, along with numerous other
geneticists.
I was fortunate to be able to meet all three successive heads of the
reconstituted Moscow Institute of Medical Genetics, Nikolai Bochkov,
Vladimir Ivanov and Yevgeny Ginter (Figure 10), and to make full
recordings with the ﬁrst and third of these [46, 47]. These showed
how difﬁcult and painful the process of rehabilitation has been, with
economic problems arising as soon as political ones had disappeared.
They also illustrated the remarkable role of Nikolai Timofeef-
Resovsky, one of the few survivors (literally) of the purge of Russian
geneticists; he was primarily a Drosophila geneticist whose main later
scientiﬁc contributions were in the area of radiation genetics and who
had the distinction of at one point heading a unit whose entire staff,
including himself, were political prisoners.
Bochkov, Ivanov and Ginter had all worked with Timofeef-
Resovsky during the 1960s in Obninsk, not far from Moscow, giving
a remarkable ‘founder effect' for Russian human and medical genetics
when it was ﬁnally resuscitated in the 1970s; the story of this as told by
Bochkov in his interview is a fascinating one, both his humble origins
and wartime struggle as a child working on the land, while his father
was away in the army, and much later his summons home while
on a travelling scholarship to American medical genetics centres, in
order to create a new institute in Moscow. Equally compelling is the
account of Zhores Medvedev (Figure 11), yet another co-worker of
Figure 9 Friedrich Vogel, Heidelberg (1925–2006).
Pioneers of European human genetics
PS Harper
9
European Journal of Human Genetics
Timofeef-Resovsky, expelled from Russia in 1972 after he had earlier
been imprisoned in a psychiatric hospital for publishing his book on
Lysenko in the West after it had been banned in Russia. His later
interview with me in London [58] focused on how these upheavals
had affected human genetics.
In St Petersburg, genetics had also been prominent in the early years
before its suppression; indeed, confusingly for the outsider, senior
workers often seem to have shuttled between Petersburg and Moscow,
and even to have directed institutes in both cities at once. In the late
1960s human genetics was cautiously revived by cytogeneticist
Aleksandra Prokovieva-Belgovskaya and medical genetics by neuro-
pathologist Sergey Davidenkov, but ofﬁcial discouragement seems to
have persisted. During my visit I was given considerable information
on the Petersburg workers but have been unable to use it fully, as it is
mostly in Russian.
Although my interviews and discussions in Moscow and
St Petersburg vividly illustrated the tribulations of Russian genetics,
an additional and unplanned interview [45] with Minsk (Belarus)
pathologist Gordon Laziuk, who had also studied genetics with
Bochkov, provided insights into the Chernobyl nuclear disaster.
Perhaps I may be allowed a word ﬁrst, though, about the background
to this. After my time in Moscow discussing and interviewing people
on historical aspects of Russian genetics, I was invited to the 2005 ﬁve
yearly all Russia Medical Genetics Congress, held in Ufa, in the
foothills of the Ural mountains, several hundred kilometres northeast
of Moscow. This event brings together human and medical geneticists
from the far ﬂung parts of the country, and includes the various
‘former Soviet Union' countries, but is not strictly international, so
that I was the only true ‘foreigner' present. The meeting gave a unique
opportunity to meet workers from many centres which I knew little
about, and which I would never have been able to travel to. Ufa itself is
a pleasant, prosperous and relaxed small city enjoying the economic
beneﬁts of oil in the region.
My interview with Gordon Laziuk, undertaken with the help of
Moscow genome scientist Nikolai Yankowsky as translator (account-
ing for the variable use of the ‘third person'), focused on the
Chernobyl disaster; he was at that time running a congenital
malformation register in Minsk, with data from several years before
the disaster occurred in 1986, which covered the regions most affected
by radiation. Unfortunately no one had any clear idea of the actual
doses of radiation involved; these were only collected or made public
outside Russia. Laziuk went immediately to the scene but found only
confusion and chaos.
‘PSH What was his personal impression being at the Chernobyl
station so soon after. Did it make a very strong personal impression,
the scene of this disaster?
GL That time was the most terrible for me. It was panic for all people
around and we didn't know anything actually. We were not informed.
We were not radiobiologists so it was a new situation. So, the maps
were created in three years. At that time no maps about how it was.
------- So I was a member of the Government Commission for that,
should have been the most informed, but I didn't know that, and
ordinary people were not aware of anything.
PSH Was there panic among the ordinary people living there?
GL Yes, ordinary people were in panic. And practically all villages
were visited by me personally.
Figure 10 (a) Nikolai Bochkov, Moscow (Born 1931). Courtesy Nikolai Bochkov. (b) Nikolai Bochkov (L), with Vladimir Ivanov (R) and Yevgeny Ginter
(centre), the three successive directors of the renewed Moscow Medical Genetics Institute. Courtesy European Society of Human Genetics.
Figure 11 Zhores Medvedev (born 1925). Courtesy Zhores Medvedev.
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PSH Has he ever written a personal, historical account of this time?
GL It's the ﬁrst time now!’
Neither he nor other experts were allowed access to relevant data,
and the ofﬁcial response was concentrated on denial and cover up;
Yankovsky commented to me that at his own Moscow institute the
only indication they had of something being wrong was when the
police appeared and removed all Geiger counters from the building.
Ironically, this was not the ﬁrst Russian nuclear disaster. In 1958, at the
secret centre in the Urals developing atomic weapons, a massive explosion
involving buried atomic waste resulted in radiation being carried by an ice
storm for hundreds of kilometres, undetected internationally only because
it remained within Russian boundaries. It was covered up not only in
Russia but by Western secret agents and governments, and Medvedev
unintentionally created a furore when after his expulsion from Russia he
published a book on it in Britain (Medvedev),25 naively assuming it
would be common public knowledge there.
To end this account of troubled times on a happier note, it was
good to see how current research and the aspirations of those working
in the ﬁeld were now (2005) fully in the mainstream of European
human and medical genetics. And as a visitor I beneﬁted from their
retention of what used to be a regular feature of most European
meetings in the days when genetics was a small and more relaxed ﬁeld
– the post-congress tour. So the day after the end of the meeting three
busloads of participants set out for the heart of the Ural mountains on
a two day visit to stay in what used to be a ‘young pioneer' camp,
located most scenically beside a limestone river gorge. It was May and
Spring was at its most beautiful, with the mixed woodland coming
into leaf. I was able soon after we arrived to slip away in the dusk
undetected by our helpful but eagle-eyed guide, and to enjoy sitting in
the forest listening to a chorus of nightingales, nightjars and cuckoos
all calling together, making me realise how much natural beauty we
have lost in Britain and many other European countries.
The Czech republic
The Czech Republic and its predecessors saw the beginning of modern
genetics with Mendel, and now are leading the way in systematically
documenting the history of human genetics in their country, but it has
been a difﬁcult road in between. Soon after it had established itself as
independent, Czechoslovakia, as it was then, was occupied by the
Nazis, engulfed in World War 2, and then forced to become part of
the post-war Soviet empire, which entailed the acceptance of
Lysenkoism, with the consequence that Mendel became reviled and
mendelism ofﬁcially unacceptable.
The ways in which this affected the various ‘Eastern Bloc' European
countries, already with established classical genetics and well developed
international links, and how they dealt with the situation, is of consider-
able historical interest and is now receiving study. In terms of my
interview series I can claim personal experience only for the Czech
Republic, though others have done interviews recently for Hungary and
former East Germany (none as yet have been published to my knowl-
edge). A lively discussion session on the topic also occurred at the
memorable Second International Workshop on Genetics, Medicine and
History held in Mendel’s abbey in Brno in 2005 (www.genmedhist.org/
workshops). I have been able to interview two Czech medical geneticists
coming from very different perspectives; Milan Macek Sr (Figure 12a),
from Prague [89] and Renata Laxova (Figure 12b) [55], originally from
Brno but later working in Britain and then in Madison, Wisconsin; both
paediatricians by background. They give accounts of early human genetics
developments in their countries, diverging as they reach the troubled
times of imposed Soviet communism and Lysenkoism.
Macek gives the ‘insider’s' viewpoint, trying to make the best of a
system that was ﬂawed yet had some valuable aspects in the way it
advanced innovations and their applications in medicine. The state
controlled system had deﬁnite advantages for the development of
medical genetics once Lysenkoist ideology could be jettisoned in the
mid 1960s; Mendel had now again become respectable, just in time for
the 1965 centenary of his work. After the end of communism Macek
found himself having to ﬁght for the maintenance of these advances in
the face of growing commercialisation of health care.
Renata Laxova’s early life is given in full in an autobiography written
primarily for her family (Laxova).26 Sent to Britain on the Kindertran-
sport as a child, her resulting ﬂuency in English proved to be a two-
edged sword when she returned to Brno after the war, placing her
under continuing suspicion as ‘contaminated by the West‘ but
allowing her to develop valuable links as a paediatrician interested
in genetics, most notably with Lionel Penrose when he visited Brno for
the Mendel centenary conference in 1965. Her vivid account of the
Penrose family’s hospitality and generosity, when she and her husband
were later forced to ﬂee the country after the 1968 Russian invasion,
Figure 12 Human genetics in Czechoslovakia. (a) Milan Macek Sr, Prague, (born 1932); (b) Renata Laxova, Brno (born 1931).
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gives insight into both Penrose’s character and into the close personal
links that can develop in a small specialty such as medical genetics,
where many of its members know each other across Europe and
indeed the world. These links helped Renata Laxova greatly in re-
establishing her career, ﬁrst in London and then in Madison,
Wisconsin.
France
France has a complex and at times unusual history in relation to
human genetics, especially in its early years, though now it is at the
forefront of mainstream medical genetics research and services.
Fortunately, I was able to make a signiﬁcant number of interviews
(15 in total) thanks largely to the hospitality of Arnold Munnich and
his colleagues at Hopital Necker, Paris, which I used as a base; I was
also helped by being able to speak French, though this often meant
that the interviews took place in a mixture of languages.
Genetics had a difﬁcult start in France, with Mendelism slow to be
accepted, as was the case with Natural Selection and Darwinism in
the 19th century; Darwin was repeatedly rejected when proposed for the
French Academy of Sciences, and there was persistent support for
Lamarckian inheritance of acquired characteristics, even though Lamarck
himself and his views had been largely ignored in his lifetime. The few
supporters of mendelism, such as Lucien Cuénot in Nancy, gained few
followers and genetics was little taught in the universities up to the 1950s.
The sudden emergence of genetics after World War 2 can partly be
attributed to the remarkable group of molecular biologists in Paris,
including Lwow, Jacob and Monod, whose links were mainly with
American basic geneticists and who had little regard for human
genetics. However a number of inﬂuential medical workers, notably
paediatricians such as Robert Debré and Maurice Lamy in Paris,
having seen the decline of infectious and nutritional causes of child
mortality, realised that genetic conditions were the next major
challenge, and that genetic research was essential if they were to be
overcome.
Lamy (Figure 13) was no longer living when I began my interviews,
but I was able to meet a number of his younger colleagues
who developed various areas of human genetics, including Pierre
Maroteaux [36], (pioneer in bone dysplasias), Josué Feingold [35]
(statistical genetics), Jean-Claude Kaplan [40] (biochemical genetics)
and most notably Jean Frézal (human gene mapping). As I cannot
possibly describe all of these interviews here, I shall simply give a
background to my interview with Frézal [44] (Figure 14), who had
emerged as successor to Lamy at Hopital Necker and as leader for the
not entirely harmonious community of French medical geneticists.
This interview provides a good example of how a prospective
interviewer may need to be persistent and opportunistic, as well as
ﬂexible, as the following background note, made at the time, indicates:
INTERVIEW WITH PROFESSOR JEAN FRÉZAL. 22 APRIL 2005
‘This interview was undoubtedly the most important of the series
undertaken in France, since Jean Frézal has been the pivotal ﬁgure in
development of the ﬁeld since the beginning. Obtaining the interview
was full of unexpected problems, however.
It was originally planned to see him during my visit last year—indeed
this was one of the main reasons for this. However, a few weeks before,
he wrote that he had been advised to have coronary bypass surgery for
angina, but that he had been assured that it was routine and he still
hoped to see me.
Arriving in Paris last April I found everyone most distressed because he
had developed serious infection postoperatively, was in intensive care
and not expected to survive. He made a very gradual recovery
however, and 6 months later was much improved.
The interview was thus top priority for the present visit, but three
weeks beforehand he had another coronary attack, though mild, so an
interview still seemed feasible. Then he was advised by his doctors to
convalesce by the sea, so I found he was no longer in Paris during my
visit, but at La Baule in Brittany.
Fortunately the excellent train service made it possible to travel to La
Baule and back in a day. So I caught the 7:30 am train from Gare
Montparnasse and was in La Baule by 11 am, after a journey through
beautiful country on a glorious spring day. I decided to divide the
interview into two sessions to avoid tiring him; the ﬁrst deals mainly
with his own work, the second with the wider development of medical
genetics in France.
As well as the interview, he and his wife took me for an excellent lunch
in La Baule, following which I was able to walk along the beach for an
hour while he rested. Leaving La Baule at 7 pm on the TGV, I was
back in Paris by 10:00 pm.’
Jean Frézal died 2 years later.
Around the same time as medical genetics was developing on a
broad base at Necker, another paediatric based group was making
major advances in cytogenetics at Hopital Trousseau, under Raymond
Turpin, which led directly to the discovery of trisomy 21 as the basis
for Down’s syndrome. This discovery was until recently associated
exclusively with the name of Jerome Lejeune, but his precise role
remains uncertain and controversial up to the present day. What is
clear is that the chromosome laboratory of Turpin’s department was
set up unaided by Marthe Gautier, who was largely excluded from
credit for the discovery until very recently. The entire topic remains a
highly sensitive one in France as a whole, and here I shall merely note
that Marthe Gautier has herself written an account to which I added a
commentary (Gautier and Harper).27 Here again is an example, all too
frequent in my interview series, of the key contributions of able female
scientists being ignored or downgraded by their male colleagues.
Figure 13 Maurice Lamy (1895–1975), pioneer of French medical genetics.
Photo courtesy of Jean Frézal.
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Lejeune’s important later role in French cytogenetics was an
undeniable, if controversial one, and helped to make Paris a major
centre for human cytogenetics, along with others such as Jean de
Grouchy and Catherine Turleau [42], based at Necker, to which
Lejeune later also moved. But Lejeune’s autocratic and extreme
Catholic views, (he sent a letter to all geneticists across France asking
them to sign a guarantee that they would not be involved in prenatal
diagnosis), caused a deep rift in French medical genetics and took
Lejeune away from any direct role in the ﬁeld. The interviews with
some of Lejeune’s former colleagues, such as Roland Berger [38],
Marie-Odile Réthoré [37] and Marthe Gautier illustrate the conﬂicting
views over Lejeune and his work.
Prenatal diagnosis was in fact developed early in France by a
remarkable husband and wife team, André and Joelle Boué
(Figure 15), neither now living, with whom I made a joint interview
[43]. Their research was based in a separate institute founded by
Robert Debré after he had retired from Hopital Necker, and thus was
insulated from some of the rivalries of Paris human genetics. Initially,
they provided a prenatal diagnostic service for most of France and the
early history of this is documented in the transcript of a 'witness
seminar' on the topic (Loewy 2010). Their account of their early years
in Iran, developing cell culture techniques in relation to vaccines, is a
fascinating one, and is given in more detail in a paper describing the
beginnings of French cytogenetics by Simone Gilgenkrantz of Nancy
(Gilgenkrantz and Rivera),28 who I was also able to interview [39].
My initial French interviews were all Paris based, not surprising in
view of the centralised nature of French science until relatively
recently, but I was keen to obtain a wider picture and to a limited
extent was able to do this by interviewing two of the key workers from
Marseille, Ségolène Aymé [85] and Jean-François Mattei [94].
Marseille was probably the ﬁrst centre in the country to develop a
comprehensive service-based medical genetics department, and its
success was in part based on the strong political connections of Mattei
and his colleague François Giraud, described below, as well as on the
organisational ability of Aymé, who was responsible also for creating
another important feature of French medical genetics, the Orphanet
web-based database and associated information services for families
with rare genetic disorders. Regarding other centres, I was able to gain
a clear picture of how human molecular genetics had evolved in
France from Jean-Louis Mandel of Strasbourg [72], complementing
that given by Paris based Jean-Claude Kaplan [40]. Interestingly, there
seems to have been little inﬂuence or direct connection with Monod,
Jacob and the other molecular biologists at Institut Pasteur. Kaplan
lamented to me that while he was training he attempted to attend
Monod’s lectures but that these were deliberately scheduled for times
when the medical workers could not come!
The above notes are quite inadequate to give the reader a coherent
picture of how French human and medical genetics has developed and
reached its current high standards. This is partly because to do so
would require a very extensive and multifaceted study, but also
because perhaps there never has been a clear single narrative to
describe. More than in any other country, I was aware of multiple
strands involving different people and centres, sometimes conﬂicting,
at others strengthening each other. Elements of this reach deep into
French society and include religious background (secular or religious,
Jewish or Catholic); gender (prominence of many female workers, yet
in the past at least discrimination against them); general political views
(left and right wing); centralisation or devolution (Paris and the rest of
France); language (Francophone or Anglophone). Many of these issues
have subsided since the events I was recording, mostly 30–50 years
ago, but others are taking their place.
As a ﬁnal note on medical genetics in France, it is relevant to its
development that a series of leading people in the ﬁeld have had
prominent political inﬂuence. Robert Debré’s son, Michel Debré was
Prime Minister under de Gaulle between 1959–1962 and reputedly
would phone his father each Sunday for advice, whereas Jean-François
Mattei was Minister of Health 2002–2004 and responsible both for
introducing a major bioethics law and for formalising the role of
genetic counsellors as a speciﬁc specialty. Jean Frézal was Rector of the
University of Paris. More recently, Arnold Munnich has been advisor
to former President Sarkozy. Altogether, it is not surprising that
human and medical genetics have been at the centre of French life to a
degree unusual in the rest of Europe.
United Kingdom
Looking at the list of my 100 interviews, it is immediately clear that the
United Kingdom represents a disproportionate number of them. This
bias is in part an artefact, resulting from being myself based in the
United Kingdom, with travel to most centres easy and virtually all
the signiﬁcant early workers personally well known to me. Also, I had
Figure 14 Jean Frézal (1922–2007), Paris. Courtesy of Jean Frézal.
Figure 15 André (1925–2012) and Joelle (1926–2014) Boué, Paris.
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the additional aim of attempting to make my coverage of UK medical
genetics, though not of human genetics more broadly, as complete as
possible, something that I had realised from the outset would be
impracticable for other countries.
I have no intention to try here to give a comprehensive account of
how UK human and medical genetics developed; that will have to
await another occasion. But I do think that a brief look at the overall
patterns and the inﬂuences on and differences from continental
Europe is worthwhile, as the United Kingdom has undoubtedly had
major inﬂuences internationally from the very beginnings of genetics.
Thinking ﬁrst of these early years, before World War 2, much of the
general genetics research was in effect human genetics, notably Francis
Galton and his 'biometric' colleagues' quantitative research on such
normal human characteristics as ﬁngerprints, height and intelligence,
even though some of this was ﬂawed. Likewise much early mendelian
research, starting with William Bateson and his collaboration with
Archibald Garrod on 'inborn errors of metabolism', dating from the
beginning of the 20th century, was human disease related. This work
had already been incorporated into medical thinking by the 1930s,
thanks to monumental contributions such as Julia Bell’s Treasury of
Human Inheritance volumes,8 and published events such as the Royal
Society of Medicine’s 'Debate on Inheritance and Disease'.
Equally important was the fact that a number of outstanding British
geneticists of this period, such as JBS Haldane and Lancelot Hogben,
used human data for their more general analyses, leading to key
advances such as the ﬁrst estimates of human mutation rate and the
ﬁrst genetic linkage in humans (haemophilia and colour-blindness).
Thus, when life and work resumed at the end of the war, the stage was
set for human genetics to emerge as a deﬁned ﬁeld of study, in
contrast to America, which had been turned away from the ﬁeld by the
abuses of eugenics, and most of continental Europe, which was still
too devastated to enter the ﬁeld rapidly.
There is no doubt that the key ﬁgure in the early post-war
development of human genetics, in the United Kingdom and world-
wide, was Lionel Penrose (1898–1972), based at London’s Galton
Laboratory. Penrose’s main work, founded on solid quantitative and
mendelian genetic principles, was in the area of mental handicap, but
his unit was a magnet for younger workers, both scientists and
clinicians, many of whom became founders in their own countries
across Europe (and in America) as well as for workers in Britain, who
progressively set up human genetics in their own centres, as posts
became available through the university and health systems.
Although Penrose (Figure 16) had died many years before I began
my interviews, one can build up a detailed picture of him through the
interviews with younger workers who had spent time at the Galton
lab. It is remarkable how many key ﬁgures across Europe who I
interviewed named him as the major inﬂuence on their career and life
in genetics, (a question that I tried to ask all interviewees), even
though they could not always say precisely why. These included Jan
Mohr [51], Jean Frézal [44], Marco Fraccaro [09], Herman vanden
Berghe [66] and others, as well as those already in the United
Kingdom such as Paul Polani [01] and George Fraser [32]. The
following quotes speak for themselves.
MF. —— intellectually what changed my life was the Galton
atmosphere. Penrose, mind you Penrose would never tell you anything
directly but he really… I mean my experience at University College, I
would never, I couldn’t possibly have come back to Italy to ﬁnd the
same situation.
(Marco Fraccaro)
PSH. —— which person in your career has had the biggest inﬂuence
on the development of your work?
JF. Penrose.
PSH. That’s very interesting.
JF. Penrose. I was very inﬂuenced by Penrose’s spirit.
(Jean Frézal)
PSH. ———can you identify, is there one particular person who you
feel had the most inﬂuence for the development of your work and
career in human genetics?
JM. Asked like that, it might be Lionel Penrose.
PSH. Yes. And would this be for any special reason?
JM. Well, as I mentioned, I liked his concern with the possibility
of getting clear answers, although he didn’t always get them himself.
(Jan Mohr)
PSH. I have talked with a large number of people who have spent time
at the Galton. Was that time an important inﬂuence for you?
HB. I would say it was like a vision upon a different world. It opened
my eyes, absolutely.
(Herman vanden Berghe)
These strongly positive feelings were despite, or perhaps because of,
an almost complete lack of organised structure for teaching or
research support in the unit, though plenty of both were available if
requested. People were encouraged to have their own ideas and to
work on them, and to utilise the wide range of expertise in other units
nearby. A major factor also was Penrose’s strong ethical stance and
respect for his patients, as well as respect for facts. After the horrors of
war and the abuses of eugenics under the Nazis, this was something
that people needed, and it is fortunate for post-war human genetics
that its recovery and development were based on Penrose and his unit
rather than on others who had been closely associated with pre-war
genetics and eugenics.
Figure 16 Lionel Penrose (1898–1972) (courtesy Professor Shirley
Hodgson).
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A second ﬁeld of major UK research advances and inﬂuence across
Europe comes from early developments in human cytogenetics. As
with much of Europe, and America too, the impetus came very largely
from the threats imposed by exposure to radiation. It had been clear
for many years that radiation could cause genetic damage in
experimental animals, both somatic and germline; following the Japan
atomic explosions, the wider development of nuclear weapons and the
radiation fallout into the atmosphere from atomic tests, very real
public and political concern developed over genetic and cancer risks at
the population level. As chromosome damage was the most visible
indicator of this at the cell level, major funding was poured into setting
up of cytogenetic laboratories, but also into wider human genetics
research.
In the UK the Medical Research Council set up two major centres
for radiation related genetic research, one in Edinburgh, with
leukaemias and cancers as its principal remit, the other at Harwell,
near Oxford, where the main UK experimental nuclear reactor was
located and which had mouse genetics as its focus. Both units
produced outstanding research involving exceptional people, and
perhaps the most valuable general lesson to be learnt comes from
the almost total freedom that the unit directors had in their choice of
research, often well outside their original remits. This freedom led to
major advances in human genetics and the MRC deserves great credit
for this too; sadly the inevitable progress of bureaucracy eventually put
an end to this laissez faire approach.
I was able to interview several members of these units (Figure 17),
including Mary Lyon [18] and Anthony Searle [19] from Harwell and
Patricia Jacobs [06] (also her technician Muriel Lee [06]), John Evans
[04] and David Harnden [08] from the Edinburgh unit. Charles Ford,
perhaps the key founder of British human cytogenetics, was no longer
living, but I was able to obtain much information (and many
anecdotes) from his former Harwell colleague Ted Evans [15]. I have
tried to put the copious information from these interviews together in
my book 'First Years of Human Chromosomes' and the full interview
transcripts are available on the Genmedhist website, as are audioclips,
which are especially pleasurable in bringing back memories of these
remarkable people, several now no longer living.
Especially notable discoveries from these units include the 1959
recognition of the XXY chromosome constitution in Klinefelter
syndrome by Patricia Jacobs, followed later by XXX and XYY
syndromes; At Harwell, Charles Ford, in conjunction with Paul Polani
in London, discovered the 45XO basis for Turner syndrome. These
discoveries led to numerous collaborations and initiatives across
Europe, along with training courses in the new chromosomal
techniques, and were a major factor in the development of the
European human cytogenetics community.
Although the Galton Laboratory under Penrose and his successors
Harry Harris and Elizabeth (Bette) Robson never developed into a
centre for medical genetics services, those who trained there helped to
provide some of the founders of clinical genetics across the country, as
did the London units of Paul Polani (Figure 1) and of Cedric Carter
and his predecessor John Fraser Roberts (Figure 18a and b). But
perhaps the greatest inﬂuence in this process was the Liverpool based
institute headed by physician Cyril Clarke (Figure 18c), who also
developed close links with Victor McKusick in Baltimore, resulting in
a series of hybrid Liverpool/Baltimore medical geneticists mostly from
adult internal medicine, who would continue the strongly clinical
approach of their parent centres into new units across the United
Kingdom. Although none of these three were still living at the time I
began my interview series, there is much information on them in the
interviews with a number of younger workers who trained with them,
including the author. The expansion of the National Health Service
gave opportunities for these centres to develop integrated genetic
services, laboratory and clinical, on a planned regional basis, a
structure that was able to accommodate the new ﬁeld of human
molecular genetics as it became progressively applicable to genetic
disorders. This pattern also resulted in a relatively 'ﬂat' and non-
hierarchical structure for delivering genetic services, in which these
were not subsidiary to the academic system, and within which new
professional groups such as non-medical genetic counsellors, could
ﬁnd a home.
A ﬁnal area in which UK human genetics has inﬂuenced the
international, particularly the European scene, has been in human
molecular genetics research in relation to genetic disorders and its
Figure 17 The UK Medical Research Council’s radiation research units produced some remarkable workers in human cytogenetics, including (a) Patricia
Jacobs, Edinburgh (born 1934) and (b) Charles Ford, Harwell (1912–1999). Photographs courtesy of Professor Patricia Jacobs; S Karger AG, Basel.
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applications in medical genetics practice. Scientists such as Bob
Williamson and Kay Davies [61; 80] were at the forefront of isolating
major disease genes, and in training workers from numerous
European centres in the new techniques. I have vivid memories
of my own group’s collaboration with them and the excitement
of the years between 1980 and 1995 when positional cloning
allowed the identiﬁcation of disease genes that before had been
entirely inaccessible, such as Huntington’s disease and the muscular
dystrophies.
Likewise, the use of molecular genetic techniques in diagnosis and
prediction has revolutionised medical genetics, and the numerous
European collaborations have allowed common policies and high
standards to be achieved which have to a large extent avoided the
major ethical and practical blunders that might well have occurred had
these applications been left to individual centres or commercial forces.
The interview with Andrew Read from Manchester [64] illustrates
some of these issues, whereas that with Angus Clarke of Cardiff [96]
shows how fruitful a careful analysis of the ethical problems can be.
Other European countries
To ignore almost completely in this article a number of countries,
especially those making up most of the southern part of the continent
may seem perverse, especially to those working there, and I can only
plead the excuse of not having interviewed sufﬁcient workers from
these countries to warrant a more general account here. As I have
emphasised previously, each country needs to make an attempt to
interview its own key pioneers, with my own series marking only a
starting point. The few interviews that I did manage to undertake in
southern Europe (Giovanni Romeo [73], Marco Fraccaro, Italy [09];
Jorge Sequeiros, Portugal [88]) give an indication of how valuable such
a systematic approach might be for these countries. For some
countries (eg, Switzerland) historical accounts have already been given
(Geiser),29 but rarely involving interviews.
My two interviews in Italy, with Marco Fraccaro and Giovanni
Romeo, illustrate the diverse origins of Italian human genetics, and
interviews with others would be likely to increase this diversity.
Fraccaro, from Pavia, had learned genetics under the early geneticist
Buzatti-Traverso (later the renowned population geneticist Luca Cavalli-
Sforza would also be based in Pavia); he was greatly inﬂuenced by his
time in Britain, where he worked ﬁrst with Penrose at the London
Galton Laboratory (see the quotation above), and later with Alan
Stevenson in Oxford; in between he took a post in Uppsala where he
met Jan Lindsten, and the two established one of the earliest European
cytogenetics laboratories, continuing to work together after Fraccaro
had returned to set up his own unit in Pavia. This became one of the
foremost Italian centres for human cytogenetics, and later for human
molecular genetics also. The interview with Fraccaro gives considerable
information about early medical genetics elsewhere in Italy.
Giovanni Romeo, by contrast, formed part of the worldwide
community of medical geneticists trained by Victor McKusick in
Baltimore, with whom he maintained lifelong links, basing the
European School of Medical Genetics, ﬁrst held in Sestri Levante in
1988, largely on McKusick’s Bar Harbor ‘Short Course in Medical
Genetics’. Subsequently Romeo became the ﬁrst elected President
of ESHG.
In Portugal, Jorge Sequeiros represents another Johns Hopkins
trainee, learning genetics originally in Porto with Amandio Tavares
and subsequently working with neurologist Corino de Andrade on
amyloid polyneuropathy, who encouraged him to go to Baltimore.
He returned to Porto to develop neurogenetics in particular and has
played a key role in establishing medical genetics as a full specialty in
Portugal.
In fact, the inﬂuence of Victor McKusick on the founding of
European Medical Genetics centres and the type of medical genetics
that was established in them would make a valuable and interesting
study, especially now that McKusick’s correspondence and other
papers have been archived at Johns Hopkins. Almost 50 years later,
this European diaspora of Johns Hopkins graduates (the author is one
of them) still maintains close bonds and personal friendships, as can
be witnessed at any European meeting.
INTERACTIONS AND DISCONNECTIONS
In the immediate post-war reconstruction of European science, the
initial steps came mainly from individual centres in different countries.
Figure 18 Some pioneers of UK medical genetics (See also Paul Polani, Figure 1). (a) John Fraser Roberts, London, (1899–1987). Courtesy Professor
Marcus Pembrey. (b) Cedric Carter, London (1917–1984). Courtesy British Society for Genetic Medicine. (c) Cyril Clarke, Liverpool (1907–2000).
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The need for interactions and collaborations in genetics was indeed
the primary reason underlying the founding of ESHG 50 years ago,
about which I have written elsewhere in this special issue of the
Society’s Journal (Harper).5 Although it is easy now to disparage
the 'minimalist' approach of Jan Mohr and other ESHG founders, the
early ESHG meetings helped to create a framework around which
more extensive developments could be based.
The most important of these developments for human genetics,
perhaps even more than for other areas of science, has of course been
the European Union itself, with its programmes of joint research,
international workshops, major speciﬁc centres and many other
initiatives, which together have ensured the leading role in the world
for European human genetics generally.
Linked to both the EU and to ESHG, but speciﬁc to genetics is the
European School of Medical Genetics (now Genetic Medicine), based
ﬁrst at Sestri Levante, then at Bertinoro, Italy, founded by Giovanni
Romeo, as described in his interview [73]. This has certainly been
one of the main unifying factors in bringing together those working
and training in numerous different areas of human and medical
genetics.
Other important factors promoting human genetics broadly across
Europe have included the far-sighted activities of major charities,
such as Rockefeller Foundation in the early years and Wellcome
Trust more recently, as well as the French Telethon and comparable
initiatives. I wish that I had been able to undertake interviews with
key people involved with these activities in different countries;
this would be a valuable project for someone. Similarly, the growing
role of lay societies for genetic disorders across Europe has been
important not only in funding and facilitating research, but as partners
alongside professionals in developing policies related to genetic
disorders.
As to ‘disconnections', without doubt, the greatest disconnection in
the history of genetics is that which occurred between Russian genetics
and genetics in the rest of the world due to imposition of the
fraudulent doctrines of Lysenko, promoted by Stalin, beginning in the
mid 1930s and extending well into the 1960s. Russian human genetics
has yet fully to recover from this catastrophic chapter.
A somewhat comparable situation resulted at the end of World War
2 in Germany (at least in West Germany as it then was), as a result of
the Nazi abuses of eugenics, which involved many prominent human
geneticists, many of whom were reinstated in their posts; this resulted
in a deep and long lasting revulsion in the general population against
the whole ﬁeld, again something which human genetics in Germany is
only now overcoming.
At a more localised level, France illustrates some important
disconnections. I have already mentioned the lack of contact between
the early molecular biologists and the emerging area of medical
genetics, perhaps just one example of a somewhat condescending
attitude of basic scientists towards applied or medical workers
that remains surprisingly widespread. The understandable but
unhelpful insistence of some prominent French geneticists (Lejeune
was a notable example) on using the French language rather than
English certainly hindered many of the earlier French workers in the
ﬁeld and limited the development of their links with Anglophone
centres.
And sadly, at a personal as well as a general level, the impending loss
of the United Kingdom from the European Union is bound to damage
the invaluable links between Britain and the rest of Europe forged over
the past half century, which for genetics have been especially fruitful.
SOME GENERAL CONCLUSIONS
I learned a great deal from undertaking my interview series, the most
important things being how little I had known previously and how
much I still had to learn. Still, I do feel that there are some clear
conclusions that can be drawn from what I have managed to do, and I
shall try to summarise them here.
First, European human and medical genetics over the past half
century have undoubtedly been a success, both in scientiﬁc terms and
also in relation to medical advances. Although there were some sound
foundations, (as well as some disastrous misapplications) before
World War 2, the ﬁeld has essentially developed from virtually
nothing during the professional lifetimes of many of those who I
was able to interview, and is now a major force in both science and
medicine.
Second, human genetics has crossed both geographical and profes-
sional boundaries to a remarkable degree, and has been marked by a
high degree of cooperation and collaboration across Europe and
generally across the world. The interviews show how much time and
effort many of the founders of the ﬁeld spent in trying to promote the
specialty as a whole, not just their own interests, with a strong
tradition of mutual help, especially in medical genetics services,
though naturally competition in research has not been absent.
The ﬁeld has also shown a strong talent for opportunism where
funding is concerned, both for research and for its translation
into medical services. Perhaps this is because over most of this
time funding has been far from easy and has required ingenuity to
obtain.
A third aspect that in my view should be regarded as a success is the
recognition of the numerous ethical problems that exist, not only in
human genetics research but in applications by medical geneticists and
by wider medical professionals. In the early years the main focus was
on prenatal diagnosis, as related to abortion; the interviews with Kåre
Berg and with Belgian and French workers show how a cautious and
responsible approach gradually overcame entrenched opposition from
religious groups. The advent of molecular genetic testing, particularly
predictive testing for adult diseases such as Huntington’s disease,
produced a further series of ethical difﬁculties; again these have been
largely avoided or overcome by a combination of awareness and
detailed collaborative analysis, something that the involvement of
social scientists has also helped with. Now the main challenge is to
ensure that other medical professionals, increasingly involved in the
new applications of genomics, also follow the standards and guidelines
that have evolved.
On the debit side, my interviews showed clearly how badly many
women of outstanding ability were treated, something that is now
diminished and certainly less overt, but probably not yet extinct. And,
as might be expected from interviews with founders who had built up
successful units from small beginnings (often just themselves), some of
them, though by no means all, found it difﬁcult to accept the
limitations of retirement and no longer being in charge of things.
All in all, my broad conclusion from 50 years in the ﬁeld of human
and medical genetics, and in particular from my interview series, is
that the ﬁeld has not only been outstanding in its scientiﬁc and
medical successes over the past half century, but that its pioneers have
been truly remarkable individuals. Of course, being from the ﬁeld
myself and interviewing people about their own work and achieve-
ments, this conclusion is bound to be a biased one; yet I do not feel
that it is far from the truth, whereas the fragmentary picture of the
beginnings and development of the ﬁeld across Europe, which I have
given here is unlikely to be contradicted by written or other evidence.
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Certainly, for me personally, undertaking the interview series
has been one of the most rewarding parts of my career in medical
genetics, especially coming at a relatively late point when one might
have felt that one had little more to contribute. I hope and sincerely
think that others, after reading the interview transcripts, will ﬁnd
enjoyment and, for the most part pride, in the stories told by these
pioneers.
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